Abstract

The unrestrained proliferation of cancer cells requires a high level of ribosome biogenesis. The first stage of ribosome biogenesis is the transcription of the large ribosomal RNAs (rRNAs); the structural and functional components of the ribosome. Transcription of rRNA is carried out by RNA polymerase I (Pol-I) and its associated holoenzyme complex.Here we report that BRCA1, a nuclear phosphoprotein, and a known tumour suppressor involved in variety of cellular processes such as DNA damage response, transcriptional regulation, cell cycle control and ubiquitylation, is associated with rDNA repeats, in particular with the regulatory regions of the rRNA gene.We demonstrate that BRCA1 interacts directly with the basal Pol-I transcription factors; upstream binding factor (UBF), selectivity factor-1 (SL1) as well as interacting with RNA Pol-I itself. We show that in response to DNA damage, BRCA1 occupancy at the rDNA repeat is decreased and the observed BRCA1 interactions with the Pol-I transcription machinery are weakened.We propose, therefore, that there is a rDNA associated fraction of BRCA1 involved in DNA damage dependent regulation of Pol-I transcription, regulating the stability and formation of the Pol-I holoenzyme during initiation and/or elongation in response to DNA damage.

Highlights

  • Ribosome biogenesis is a fundamental cellular process that is tightly regulated by an elaborate network of cellular signalling cascades which respond to a variety of intra- and extra-cellular stimuli [1,2,3,4,5,6]

  • BRCA1 is associated with the promoter regions and interestingly a significant fraction of BRCA1 is associated with intergenic spacers (IGS), which contain a number of cryptic promoters and regulatory sequences in addition to various repetitive sequences (i.e. Alu repeats)

  • IGS is not transcribed by polymerase I (Pol-I), but it is a source of a number of non-coding regulatory RNAs transcribed by polymerase II (Pol-II) which may be responsible for BRCA1 loading to IGS

Read more

Summary

Introduction

Ribosome biogenesis is a fundamental cellular process that is tightly regulated by an elaborate network of cellular signalling cascades which respond to a variety of intra- and extra-cellular stimuli [1,2,3,4,5,6]. In normal cells rRNA synthesis is kept under tight control by various oncogenes and tumour suppressors including p53, Rb, C-MYC, Ppan, CKII and PTEN, and it is evident that cancer cells have lost some of these restraints [2, 4, 14,15,16,17]. It is reasonable to hypothesise that pathways leading to upregulation of ribosome biogenesis are different in different types of malignant cells because different oncogenes and tumour suppressors are affected in different types of cancers. BRCA1 is 220 kDa nuclear phosphoprotein and known tumour suppressor which is involved in a variety of cellular processes such as DNA damage response, transcriptional regulation, cell cycle control and ubiquitylation [18,19,20,21]. BRCA1 has been shown to play the role of a general repressor of RNA www.impactjournals.com/oncotarget

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call